Mounjaro Shows Promise for Kids and Teens with Type 2 Diabetes
Eli Lilly’s diabetes drug Mounjaro (tirzepatide) is moving closer to approval for children and teens after strong results from a new clinical trial. The phase 3 SURPASS-PEDS study tested the drug in 99 patients ages 10 to 17 who struggled to control their blood sugar with common treatments like metformin and insulin. After 30 weeks,
